Cepheid, Bruker, and Qiagen Shares All Rise in Double Digits | GenomeWeb

The stocks of Cepheid, Bruker BioSciences, and Qiagen all gained more than 10 percent for the five-day trading period ended Tuesday.
Cepheid led all gainers in the BCW Index for the week with a 12.6 percent rise in its shares. The firm is due to report its third-quarter results on Nov. 1.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.